(Total Views: 606)
Posted On: 04/14/2025 5:51:17 PM
Post# of 154743
Long-acting Leronlimab for cancer:
After mTNBC news I posted about this possibility & our patent application is for cancer LL-PLS
Includes using the same FcRn abstract mutations.
LL-PLS in the "36+" month ladies or if is used in the next phase ???
From today filing:
Triple-Negative Breast Cancer:
Long-acting version of leronlimab
Wow @ the potential !!....
After mTNBC news I posted about this possibility & our patent application is for cancer LL-PLS
Includes using the same FcRn abstract mutations.
LL-PLS in the "36+" month ladies or if is used in the next phase ???
From today filing:
Triple-Negative Breast Cancer:
Long-acting version of leronlimab
Wow @ the potential !!....
(3)
(0)
